Press Releases

Annual General Meeting of Active Biotech AB
June 12, 2015 08:30 (CEST)
Active Biotech focuses the operations on the laquinimod project and adjusts the organization
June 1, 2015 10:03 (CEST)
Active Biotech focuses the operations on the laquinimod project and adjusts the organization
June 1, 2015 10:00 (CEST)
Notice of Annual General Meeting of Shareholders
May 12, 2015 08:40 (CEST)
Notice of Annual General Meeting of Shareholders
May 12, 2015 08:30 (CEST)
Annual Report 2014 Active Biotech AB (publ)
April 30, 2015 10:04 (CEST)
Annual Report 2014 Active Biotech AB (publ)
April 30, 2015 10:00 (CEST)
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
April 23, 2015 20:32 (CEST)
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
April 23, 2015 20:00 (CEST)
Active Biotech AB Interim report January - March 2015
April 23, 2015 08:34 (CEST)